Fidelity Investments’s LakeShore Biopharma LSB Stock Holding History

Fidelity Investments’s Portfolio LSB Stock Details LSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-116,508	Closed	-$119K	–	5609
2025 Q2	$119K	Hold	116,508	–	–	﹤0.01%	3537
2025 Q1	$282K	Hold	116,508	–	–	﹤0.01%	3121
2024 Q4	$402K	Buy	116,508 +1	+0%	+$3	﹤0.01%	3008
2024 Q3	$803K	Hold	116,507	–	–	﹤0.01%	2666
2024 Q2	$755K	Hold	116,507	–	–	﹤0.01%	2606
2024 Q1	$816K	Hold	116,507	–	–	﹤0.01%	2569
2023 Q4	$627K	Hold	116,507	–	–	﹤0.01%	2609
2023 Q3	$932K	Hold	116,507	–	–	﹤0.01%	2468
2023 Q2	$1.61M	Hold	116,507	–	–	﹤0.01%	2378
2023 Q1	$1.86M	Buy	+116,507	New	+$5.9M	﹤0.01%	2379

Other funds holding LSB

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Fidelity Investments's LSB Position: Q3 2025 in Review

Fidelity Investments sold out of LakeShore Biopharma (LSB) in Q3 2025, closing a stake of 116,508 shares — an estimated $119K sold.

Fidelity Investments first reported a position in LSB in Q1 2023 and held it in 10 quarters. The position peaked at $1.86M in Q1 2023. 1 fund tracked by Wall St. Rank holds LSB as of Q3 2025.

Fidelity Investments reported no remaining LakeShore Biopharma position as of Q3 2025 after selling out during the quarter.
Fidelity Investments sold 116,508 LakeShore Biopharma shares in Q3 2025, an estimated $119K.
Fidelity Investments first reported a position in LakeShore Biopharma in Q1 2023 and held it in 10 quarters.
Fidelity Investments's LakeShore Biopharma position peaked at $1.86M in Q1 2023.
1 fund tracked by Wall St. Rank held LakeShore Biopharma as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.